Article info
Basic and translational research
Extended report
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma
- Correspondence to Dr Francesco Del Galdo, Division of Rheumatic and Musculoskeletal Diseases, Leeds Institute of Molecular Medicine, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds ls9 7pf, UK; f.delgaldo{at}leeds.ac.uk
Citation
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma
Publication history
- Received September 17, 2012
- Revised December 19, 2012
- Accepted January 27, 2013
- First published February 20, 2013.
Online issue publication
October 03, 2013
Article Versions
- Previous version (20 February 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions